WallStSmart
LRMR

Larimar Therapeutics Inc

NASDAQ: LRMR · HEALTHCARE · BIOTECHNOLOGY

$4.06
-6.45% today

Updated 2026-04-30

Market cap
$461.24M
P/E ratio
P/S ratio
EPS (TTM)
$-2.27
Dividend yield
52W range
$2 – $6
Volume
5.0M

Larimar Therapeutics Inc (LRMR) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-23.6%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-62.2%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-3.3%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-8.7%
2025-11-05
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-18$-0.73-49.0%$4.38$4.47+2.1%
2025-11-05$-0.61-47.8%$3.80$3.47-8.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.49$-0.73-49.0%
2025-09-30$-0.41$-0.61-47.8%
2025-06-30$-0.48$-0.41+14.6%
2025-03-31$-0.41$-0.46-12.4%
2024-12-31$-0.32$-0.45-40.9%$482000.00
2024-09-30$-0.37$-0.24+35.1%
2024-06-30$-0.31$-0.34-9.7%
2024-03-31$-0.23$-0.27-17.4%
2023-12-31$-0.25$-0.30-20.0%
2023-09-30$-0.22$-0.21+4.5%
2023-06-30$-0.19$-0.19+0.0%
2023-03-31$-0.25$-0.15+40.0%

Frequently asked questions

Has Larimar Therapeutics Inc beaten earnings estimates?
Larimar Therapeutics Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -23.6% over the last 4 quarters.
How does LRMR stock react to earnings?
LRMR stock has moved an average of -3.3% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.